Daily Technology News

Technology News and Press Release Distribution Services

About US | Contact Us

Home | Technology News | Submit Press Release | Submit RSS Feed
Unlimited Press Release Distribution
Press release distribution service

IT News Media

CIO News
PC World
Tech Republic
Wall Street Journal Digital
Submit press release to these Tech media distribution list.

Technology News Releases

Immunosuppressants Drugs Market – Global Industry Perspective, Comprehensive Analysis and Forecast, 2021 – 2028

(IT-NEWSWIRE.COM, October 13, 2021 )

Market Overview

Immunosuppressant drugs are a class of drugs that suppress, or reduce, the strength of the bodys immune system. During organ transplantation, from a donor to a recipient, the immune system of the recipient gets stimulated and thus, produces an immune response like it does in response to other foreign material.

This immune response causes serious damage to the transplanted or grafted organ. It is often called rejection, which can be acute or chronic. This organ rejection is prohibited by using immunosuppressive drugs, which block the immune response and protect the new organ and its function.

View full report: https://bit.ly/3FGILgf

Market Dynamics

The global immunosuppressants drugs market growth is driven by innovations and advancements in organ transplantation procedures. The rise in the volume of these procedures is driving the growth of the market in the forecast period.

The increasing prevalence of diabetes is expected to drive the growth in the forecast period

An immunosuppressant is an agent that can suppress or prevent the immune response. Immunosuppressants drugs are used to prevent rejection of a transplanted organ and to treat autoimmune diseases such as type 1 diabetes, rheumatoid arthritis, psoriasis/psoriatic arthritis, multiple sclerosis, systemic lupus erythematosus (SLE), inflammatory bowel disease, Addisons disease, and graves' disease among others. Commonly used immunosuppressants drugs include tacrolimus, cyclosporine A, glucocorticoids, methotrexate, and rituximab.

According to the 2017 report of the International Diabetes Federation (IDF), approximately 425 million adults (20-79 years) were suffering from diabetes, and by 2045 this number may rise to 629 million, globally.

Several government organizations and NGOs are working to increase awareness about the socioeconomic impact of autoimmunity through fostering and facilitating collaboration in the areas of education, public awareness, research, and patient services in an effective, ethical, and efficient manner. This factor will drive the growth of the market in the forecast period.

Market Segmentation:

By Drug Class

Calcineurin Inhibitors

Antiproliferative Agents

mTOR Inhibitor

By Indication

Organ Transplantation

Autoimmune Disorders

Non-Autoimmune Inflammatory Diseases

By Distribution Channel

Hospital Pharmacy

Pharmacy Stores

Download free sample: https://bit.ly/3iWThGk

Geographical Analysis

North America region holds the largest market share global immunosuppressants drugs market

North America is expected to hold a major market share in the global immunosuppressant drugs market due to the increasing prevalence of autoimmune diseases and the rapid rise in the number of organ transplants in this region.

According to the Centers for Disease Control (CDC), in the year 2017, it was estimated that approximately 19 percent of men and 25 percent of women in the United States had doctor-diagnosed arthritis, in addition, doctor-diagnosed arthritis was prevalent in 16.4 percent of people who were underweight, while 27.7 percent of individuals who were obese.

Furthermore, technological advancements in tissue engineering and organ transplantations, increasing healthcare spending coupled with increasing investments in research and development, and the presence of well-established healthcare infrastructure are also fueling the growth of the overall regional market to a large extent.

Drug classes such as CETP inhibitors have been withdrawn or discontinued even in the later stages of trials due to adverse effects or failure to achieve satisfactory results. Risks associated with immunosuppressants pose a major challenge to their entry into the market.

Competitive Landscape

The immunosuppressants drugs market is moderately competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Astellas Pharma, Inc, Sanofi (Genzyme), Bristol-Myers Squibb Company, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc, GlaxoSmithKline Plc, Allergan Plc, Accord Healthcare Ltd, and Mylan Laboratories, Inc. among others.

The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the immunosuppressants drugs market globally.

Related Topic's

Autoimmune Treatment Market, Allergy Immunotherapies Market, Thrombocytopenia Management Market, Systemic Lupus Erythematosus Market, Systemic Sclerosis Market

DataM Intelligence

Sai Kiran

+1 877 441 4866


Source: EmailWire.Com

Technology News By Sector
  • Application Development
  • Big Data
  • Desktops
  • Cloud Computing
  • Data Centers
  • Mobile Computing
  • OS
  • Open Source
  • Security
  • Virtualization

     Sign-Up To Our Free Newsletter!  
    IT-NewsWire Newsletter

    Technology Marketplace

    Free Information Technology Magazines, Downloads
    Get free tech publications including magazines and white papers
    Amazon, Inc News Headlines
    Read breaking news about Amazon.com as reported by TV news anchors and summaries news articles from New York Times

    Free Computer Security Magazines
    Download or subscribe to latest IT Security publications -- free of charge.

    Microsoft News
    Microsoft financial and at Work: read news about MSFT hardware, software and services.
    Submit RSS News Feed.
    Have your feed on news, products or services displayed under this marketpalce. The feed is also displayed on a full page and updated daily. Add RSS feed Now!

    Press release distribution services: Submit press release to major media. Unlimited press release service

    For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com.

    IT-Newswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright 2013 GroupWeb Media LLC. All Rights Reserved.

    GroupWeb Media Network
    AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
    | InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
    IT-NewsWire.Com - Newswire and Press Release service of GroupWeb Media LLC